title: Chemopreventive mechanisms of α-keto acid metabolites of naturally occurring organoselenium compounds.
abstract: Previous studies on the chemopreventive mechanisms of dietary selenium have focused on its incorporation into antioxidative selenoproteins, such as glutathione peroxidase and thioredoxin reductase. Several studies, however, have revealed that dietary selenium in the form of L-selenomethionine and the 21st amino acid, selenocysteine, also have intrinsic anti-cancer properties. Biochemical mechanisms previously investigated to contribute to their anticancer effects involve β- and γ-lyase reactions. Some pyridoxal 5'-phosphate (PLP)-containing enzymes can catalyze a β-lyase reaction with Se-methyl-L-selenocysteine (MSC) generating pyruvate and ammonia. Other PLP-enzymes can catalyze a γ-lyase reaction with L-selenomethionine (SM) generating α-ketobutyrate and ammonia. In both cases, a purported third product is methylselenol (CH(3)SeH). Although not directly quantifiable, as a result of its extreme hydrophobicity and high vapor pressure, CH(3)SeH has been indirectly observed to act through the alteration of protein-sulfhydryl moieties on redox-responsive signal and transcription factors, thereby maintaining a non-proliferative intracellular environment. We have considered the possibility that α-keto acid analogues of MSC (i.e., methylselenopyruvate; MSP) and SM (i.e., α-keto-γ-methylselenobutyrate; KMSB), generated via a transamination and/or L-amino acid oxidase reaction may also be chemoprotective. Indeed, these compounds were shown to increase the level of histone-H3 acetylation in human prostate and colon cancer cells. MSP and KMSB structurally resemble butyrate, an inhibitor of several histone deacetylases. Thus, the seleno α-keto acid metabolites of MSC and SM, along with CH(3)SeH derived from β- and γ-lyase reactions, may be potential direct-acting metabolites of organoselenium that lead to de-repression of silenced tumor suppressor proteins and/or regulation of genes and signaling molecules.
authors.affiliation: Department of Biochemistry and Molecular Biology, New York Medical College, Valhalla, 10595, USA. John_pinto@nymc.edu
authors.forename: John T
authors.initials: JT
authors.lastname: Pinto
authors.forename: Jeong-In
authors.initials: JI
authors.lastname: Lee
authors.forename: Raghu
authors.initials: R
authors.lastname: Sinha
authors.forename: Melanie E
authors.initials: ME
authors.lastname: MacEwan
authors.forename: Arthur J L
authors.initials: AJ
authors.lastname: Cooper
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D006801:Humans; D007651:Keto Acids / Q000737:chemistry / Q000378:metabolism*; D016566:Organoselenium Compounds / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D007651:Keto Acids; D016566:Organoselenium Compounds
references.citation: Cancer Res. 2008 Dec 15;68(24):10290-9
references.pmid: 19074897
references.citation: Nat Med. 2005 Jan;11(1):71-6
references.pmid: 15619634
references.citation: Int J Cancer. 2007 Apr 1;120(7):1410-7
references.pmid: 17205524
references.citation: Cancer Res. 2000 Jun 1;60(11):2882-6
references.pmid: 10850432
references.citation: Eur J Biochem. 2001 Jun;268(11):3346-53
references.pmid: 11389738
references.citation: J Cell Biochem. 2009 Jul 1;107(4):600-8
references.pmid: 19459166
references.citation: Am J Transl Res. 2009 May 25;1(4):341-51
references.pmid: 19956446
references.citation: Cancer Res. 2002 May 1;62(9):2540-5
references.pmid: 11980647
references.citation: Mol Interv. 2009 Feb;9(1):18-21
references.pmid: 19299660
references.citation: Carcinogenesis. 2009 Aug;30(8):1416-23
references.pmid: 19528666
references.citation: JAMA. 1996 Dec 25;276(24):1957-63
references.pmid: 8971064
references.citation: Neurochem Int. 2004 Jun;44(8):557-77
references.pmid: 15016471
references.citation: Mol Cancer Ther. 2002 Oct;1(12):1059-66
references.pmid: 12481429
references.citation: Br J Cancer. 2004 Jul 19;91(2):195-9
references.pmid: 15213714
references.citation: J Urol. 2001 Oct;166(4):1311-5
references.pmid: 11547064
references.citation: Mini Rev Med Chem. 2008 Sep;8(10):1020-31
references.pmid: 18782054
references.citation: Expert Opin Ther Targets. 2008 Nov;12(11):1457-67
references.pmid: 18851700
references.citation: Br J Nutr. 2008 Jun;99(6):1190-8
references.pmid: 18062829
references.citation: Carcinogenesis. 2008 May;29(5):1005-12
references.pmid: 18310093
references.citation: Nat Rev Drug Discov. 2006 Sep;5(9):769-84
references.pmid: 16955068
references.citation: Cancer Res. 2009 Feb 1;69(3):958-66
references.pmid: 19176386
references.citation: Nutr Cancer. 2008;60(2):267-75
references.pmid: 18444160
references.citation: Eur J Biochem. 1976 Mar 16;63(1):163-73
references.pmid: 1261544
references.citation: Am J Transl Res. 2009;1(1):62-71
references.pmid: 19966939
references.citation: Adv Enzymol Relat Areas Mol Biol. 1998;72:199-238
references.pmid: 9559054
references.citation: Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):673-8
references.pmid: 15637150
references.citation: Curr Cancer Drug Targets. 2004 Feb;4(1):13-28
references.pmid: 14965264
references.citation: Antioxid Redox Signal. 2007 Jan;9(1):25-47
references.pmid: 17115886
references.citation: Environ Health Perspect. 2009 Sep;117(9):1409-13
references.pmid: 19750106
references.citation: Nutr Cancer. 2001;40(1):34-41
references.pmid: 11799920
references.citation: Br J Nutr. 2004 Jan;91(1):11-28
references.pmid: 14748935
references.citation: J Clin Oncol. 2009 Nov 10;27(32):5459-68
references.pmid: 19826124
references.citation: Anal Biochem. 1968 Nov;26(2):313-9
references.pmid: 4394442
references.citation: Arch Biochem Biophys. 2008 Jun 1;474(1):72-81
references.pmid: 18342615
references.citation: BJU Int. 2003 May;91(7):608-12
references.pmid: 12699469
references.citation: Carcinogenesis. 2008 Sep;29(9):1816-24
references.pmid: 18628250
references.citation: Environ Mol Mutagen. 2009 Apr;50(3):213-21
references.pmid: 19197985
references.citation: Blood. 2007 Jul 1;110(1):220-7
references.pmid: 17356132
references.citation: Proc Natl Acad Sci U S A. 2000 Aug 29;97(18):10014-9
references.pmid: 10954755
references.citation: Clin Ter. 2008 Sep-Oct;159(5):347-60
references.pmid: 18998037
references.citation: Biol Trace Elem Res. 2005 Winter;108(1-3):245-57
references.pmid: 16327076
references.citation: Nat Rev Urol. 2009 Aug;6(8):429-39
references.pmid: 19657377
references.citation: Int J Oncol. 2008 Aug;33(2):375-80
references.pmid: 18636159
references.citation: Curr Cancer Drug Targets. 2004 Mar;4(2):205-18
references.pmid: 15032670
references.citation: Ann N Y Acad Sci. 1990;585:118-27
references.pmid: 2192607
references.citation: Enzymologia. 1960 Sep 1;22:161-73
references.pmid: 13691729
references.citation: J Immunol. 2004 Oct 1;173(7):4561-7
references.pmid: 15383589
references.citation: Singapore Med J. 2009 Mar;50(3):265-9
references.pmid: 19352569
references.citation: Breast Cancer Res. 2005;7(5):R699-707
references.pmid: 16168115
references.citation: JAMA. 2009 Jan 7;301(1):39-51
references.pmid: 19066370
references.citation: Biochem J. 2000 Aug 15;350 Pt 1:199-205
references.pmid: 10926844
references.citation: Biol Chem. 2007 Oct;388(10):997-1006
references.pmid: 17937613
references.citation: Antioxid Redox Signal. 2007 Jul;9(7):775-806
references.pmid: 17508906
references.citation: J Biol Chem. 2002 May 24;277(21):19080-6
references.pmid: 11907037
references.citation: Mol Cancer Res. 2007 Oct;5(10):981-9
references.pmid: 17951399
references.citation: Arch Biochem Biophys. 1967 Oct;122(1):164-73
references.pmid: 6076213
references.citation: Cancer Res. 2004 Dec 15;64(24):9209-16
references.pmid: 15604294
references.citation: Nutr Cancer. 2009;61(3):285-6
references.pmid: 19373601
references.citation: Chem Res Toxicol. 2002 Dec;15(12):1610-8
references.pmid: 12482244
references.citation: Int J Cancer. 2009 Aug 15;125(4):774-82
references.pmid: 19384952
references.citation: Anticancer Agents Med Chem. 2008 Aug;8(6):598-602
references.pmid: 18690824
references.citation: Mol Carcinog. 2002 Jul;34(3):113-20
references.pmid: 12112305
references.citation: Toxicol Appl Pharmacol. 2008 Feb 15;227(1):76-83
references.pmid: 18035386
references.citation: Mol Cancer Ther. 2002 Oct;1(12):1079-87
references.pmid: 12481431
references.citation: Biochem Mol Biol Int. 1994 Jan;32(1):79-86
references.pmid: 8012292
references.citation: FASEB J. 2009 Aug;23(8):2514-20
references.pmid: 19276171
references.citation: Carcinogenesis. 1999 Sep;20(9):1657-66
references.pmid: 10469608
references.citation: Bioorg Med Chem. 2005 Nov 1;13(21):6070-82
references.pmid: 16006131
references.citation: J Natl Cancer Inst. 2005 Jan 19;97(2):94-102
references.pmid: 15657339
references.citation: Carcinogenesis. 2009 Nov;30(11):1941-8
references.pmid: 19759193
references.citation: J Nutr. 2009 Sep;139(9):1613-8
references.pmid: 19625696
references.citation: Urol Oncol. 2003 Jan-Feb;21(1):59-65
references.pmid: 12684129
references.citation: Cancer Res. 2004 Aug 15;64(16):5767-74
references.pmid: 15313918
references.citation: Oncogene. 2007 Aug 13;26(37):5541-52
references.pmid: 17694093
references.citation: Biochem Pharmacol. 2005 Jan 15;69(2):209-20
references.pmid: 15627473
references.citation: Nutr Cancer. 2001;40(1):64-73
references.pmid: 11799926
references.citation: Mol Nutr Food Res. 2008 Nov;52(11):1281-8
references.pmid: 18686292
references.citation: J Pharmacol Exp Ther. 2000 Aug;294(2):753-61
references.pmid: 10900257
references.citation: J Toxicol Sci. 2009 Apr;34(2):191-200
references.pmid: 19336976
references.citation: J Nutr. 1998 Nov;128(11):1845-54
references.pmid: 9808633
references.citation: Cancer Prev Res (Phila). 2009 Jul;2(7):683-93
references.pmid: 19584079
references.citation: Cancer Lett. 2009 Aug 8;280(2):125-33
references.pmid: 19359091
references.citation: J Biol Chem. 1986 Nov 25;261(33):15529-37
references.pmid: 3782077
references.citation: J Natl Cancer Inst. 1996 Nov 20;88(22):1623-34
references.pmid: 8931606
references.citation: EMBO J. 2005 Mar 9;24(5):1021-32
references.pmid: 15692560
references.citation: Leukemia. 2009 May;23(5):952-60
references.pmid: 19436310
references.citation: Cancer Res. 2002 Dec 1;62(23):7050-8
references.pmid: 12460926
references.citation: Chem Res Toxicol. 2009 Nov;22(11):1795-801
references.pmid: 19715347
references.citation: J Biol Chem. 1952 May;197(1):319-30
references.pmid: 12981062
references.citation: Adv Exp Med Biol. 2008;615:261-98
references.pmid: 18437899